The spectrum of BRCA1 and BRCA2 alleles in Latin America and the Caribbean: a clinical perspective Julie DutilVolha A. GolubevaAlvaro N. Monteiro Review Open access 12 November 2015 Pages: 441 - 453
Breast cancer-related lymphoedema and venepuncture: a review and evidence-based recommendations Adam D. JakesChris Twelves Review 20 November 2015 Pages: 455 - 461
Mutation analysis of PALB2 gene in French breast cancer families Francesca DamiolaInès SchultzDanièle Muller Preclinical study 12 November 2015 Pages: 463 - 471
LINC00472 expression is regulated by promoter methylation and associated with disease-free survival in patients with grade 2 breast cancer Yi ShenZhanwei WangHerbert Yu Preclinical study 13 November 2015 Pages: 473 - 482
Gene expression alterations associated with outcome in aromatase inhibitor-treated ER+ early-stage breast cancer patients Karina G. ThomsenMaria B. LyngHenrik J. Ditzel Preclinical study 19 November 2015 Pages: 483 - 494
Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3a Adam R. WolfeBisrat G. DebebWendy A. Woodward Preclinical Study 21 November 2015 Pages: 495 - 508
Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trial Javier CortesStacie HudgensGalina Velikova Clinical Trial Open access 14 November 2015 Pages: 509 - 520
High levels at baseline of serum pyridinoline crosslinked carboxyterminal telopeptide of type I collagen are associated with worse prognosis for breast cancer patients Michiko ImamuraArisa NishimukaiYasuo Miyoshi Clinical Trial 16 November 2015 Pages: 521 - 531
Prospective assessment of the decision-making impact of the Breast Cancer Index in recommending extended adjuvant endocrine therapy for patients with early-stage ER-positive breast cancer Tara SanftBilge AktasLajos Pusztai Clinical trial Open access 14 November 2015 Pages: 533 - 541
ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer Brian Leyland-JonesKathryn P. GrayBIG 1-98 Collaborative Group Clinical trial 21 November 2015 Pages: 543 - 555
Surgical biopsy is still necessary for BI-RADS 4 calcifications found on digital mammography that are technically too faint for stereotactic core biopsy Deborah O. JeffriesColleen H. NealMark A. Helvie Clinical trial 20 November 2015 Pages: 557 - 561
Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer Zhaomei MuChun WangMassimo Cristofanilli Epidemiology 16 November 2015 Pages: 563 - 571
Prenatal factors and infant feeding in relation to risk of benign breast disease in young women Catherine S. BerkeyBernard RosnerGraham A. Colditz Epidemiology 18 November 2015 Pages: 573 - 582
SNPs and breast cancer risk prediction for African American and Hispanic women Richard AllmanGillian S. DiteCharles Kooperberg Epidemiology Open access 20 November 2015 Pages: 583 - 589
Correlation between progression-free survival and overall survival in metastatic breast cancer patients receiving anthracyclines, taxanes, or targeted therapies: a trial-level meta-analysis George AdunlinJohn W. W. CyrusGeorge Dranitsaris Epidemiology 23 November 2015 Pages: 591 - 608
Benefit/risk for adjuvant breast cancer therapy with tamoxifen or aromatase inhibitor use by age, and race/ethnicity R. T. ChlebowskiR. HaqueG. Anderson Epidemiology 24 November 2015 Pages: 609 - 616
The 8th international symposium on the breast: Using next-generation science to understand the normal breast and the development of breast cancer- conference report Ameer GomberawallaSusan Love Brief Report 28 October 2015 Pages: 617 - 621
Potentiated suppression of Dickkopf-1 in breast cancer by combined administration of the mevalonate pathway inhibitors zoledronic acid and statins Andy GöbelAndrew J. BrowneTilman D. Rachner Brief Report 29 October 2015 Pages: 623 - 631
Long-term outcomes among breast cancer patients with extensive regional lymph node involvement: implications for locoregional management Lior Z. BraunsteinSigolene Galland-GirodetAlphonse G. Taghian Brief Report 20 November 2015 Pages: 633 - 639
